SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003753
Filing Date
2021-11-09
Accepted
2021-11-09 16:16:44
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-20210930.htm   iXBRL 10-Q 2684573
2 EX-31.1 dsgn-ex31_1.htm EX-31.1 20091
3 EX-32.1 dsgn-ex32_1.htm EX-32.1 14041
  Complete submission text file 0000950170-21-003753.txt   8562379

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dsgn-20210930_lab.xml EX-101.LAB 398395
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dsgn-20210930.xsd EX-101.SCH 51750
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dsgn-20210930_pre.xml EX-101.PRE 293720
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dsgn-20210930_def.xml EX-101.DEF 168784
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dsgn-20210930_cal.xml EX-101.CAL 43272
9 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20210930_htm.xml XML 1570502
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 211392422
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences